A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients

NCT01408602 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Molecular Research Center, Inc.

Collaborators